Skip to main content

Therapeutic Aspects and Diagnosis of the Attention Deficit Hyperactivity Disorder—ADHD in Adults

  • Conference paper
  • First Online:

Part of the book series: IFMBE Proceedings ((IFMBE,volume 73))

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is characterized by difficulties in modulating attention and hyperactivity/impulsivity. It is a very common disorder in childhood compromising school performance, hampering interpersonal relationships and causing low self-esteem that can continue in adult life and bring even more damage to the execution of routine activities in patients lives. The most commonly used treatment for ADHD is through psychostimulant drugs, however, association with other therapies is important to ameliorate the symptoms of hyperactivity. There by the treatment should be multidisciplinary, where several professionals with the family should be accompanying and treating individuals with ADHD. The objective of this study was to highlight the importance of early diagnosis and the contribution of knowledge acquisition on the nuances in the diagnosis of ADHD in adults even during medical training and multidisciplinary therapeutic procedures to improve the symptoms of adult patients with ADHD. It is concluded that the pharmacological treatment is quite effective, mainly regarding the use of methylphenidate as psychostimulant, presenting a very satisfactory profile of side effects. In some individuals with the disorder, pharmacological treatment is not sufficient because the symptoms persist or there are comorbidities. In these cases, multidisciplinary treatment with psychopharmaceuticals, psychotherapies, school and family follow-up is necessary to alleviate symptoms, leading individuals with ADHD to participate in activities common to all in the family and in society, thus preventing conduct disorders and delinquency. Therefore, the early diagnosis of ADHD with a correct treatment institution is essential for a better prognosis of the patient.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Farré-Riba, A., Narbona, J.: EDAH: Escala para la evaluación del trastorno por deficit de atención con hiperactividad. TEA, Madrid (2001)

    Google Scholar 

  2. American Psychiatric Association: DSM-5. Manual diagnóstico e estatístico de transtornos mentais, 5 edn. (2014). ISBN 9788582710883

    Google Scholar 

  3. Silva, A.B.B.: Mentes inquietas: entendendo melhor o mundo das pessoas distraídas, impulsivas e hiperativas. Napedes, Rio de Janeiro (2003)

    Google Scholar 

  4. Bastos, F.L., Thompson, T.A., Martinez, O.C.A.: Uma revisão do distúrbio de Déficit de Atenção/Hiperatividade. Apresentado no 1º Encontro Brasileiro de Neurologia, Outubro de 2000

    Google Scholar 

  5. Gomes, M., Palmini, A., Barbirato, F., Rohde, L.A., Mattos, P.: Conhecimento sobre o transtorno de déficit de atenção/hiperatividade no Brasil. J. Bras. Psiquiatr. 56(2), 94–101 (2007)

    Article  Google Scholar 

  6. Antoniuk, S.A.: Transtorno de Déficit de Atenção e Hiperatividade Conceitos e dilemas. J. Paranaense Pediatr. 3(1) (2002)

    Google Scholar 

  7. Popper, C.: Antidepressants in the treatment of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 58(suppl 14), 14–29 (1997)

    Google Scholar 

  8. Smith, C.: Dificuldades de Aprendizagem de A a Z, 1 edn. Ed. Artes Médicas (2001)

    Google Scholar 

  9. Brazilian Association of Deficit of Attention—ABDA. https://tdah.org.br/depressao-e-tdah-parte-i/ (2016). Accessed 20 Aug 2018

  10. Connor, D.F.: Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J. Dev. Behav. Pediatr. 23, S1–S9 (2002)

    Article  Google Scholar 

  11. Ritalina ® e Ritalina ® LA (coridrato de metilfenidato); Novartis Biociência SA; comprimidos 10 mg, pápsulas 10, 20, 30 ou 40 mg. Anvisa. http://www.anvisa.gov.br/datavisa/fila_bula/frmVisualizarBula.asp?pNuTransacao=24848562016&pIdAnexo=4017454 (2016). Accessed 20 Aug 2018

Download references

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samuell Ferreira .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Ferreira, S. et al. (2020). Therapeutic Aspects and Diagnosis of the Attention Deficit Hyperactivity Disorder—ADHD in Adults. In: Badnjevic, A., Škrbić, R., Gurbeta Pokvić, L. (eds) CMBEBIH 2019. CMBEBIH 2019. IFMBE Proceedings, vol 73. Springer, Cham. https://doi.org/10.1007/978-3-030-17971-7_114

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17971-7_114

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17970-0

  • Online ISBN: 978-3-030-17971-7

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics